 |
| Home > News > Publications > Journal publications |
|
| Journal publications |
|
|
| Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium |
| Waterbury D.L., Silliman D., Jolas T. |
| Current medical research and opinion, Vol. 22, No. 6, 2006, 1133–1140 |
|
|
| Construction of a homogeneous and informative in vitro profiling database for anticipating the clinical effects of drugs |
| Froloff N., Hamon V., Dupuis P., Otto-Bruc A., Mao B., Merrick S. and Migeon J. |
| In: Jacoby, E. (Ed.), Chemogenomics Knowledge-based Approaches to Drug Discovery, Imperial College Press, London, pp. 175-206. |
|
|
| Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101): A small molecule antagonist of leukocyte function associated antigen-1 |
| Potin, D., Launay M., Monatlik F., Malabre P., Fabreguettes M., Fouquet A., Maillet M., Nicolai E., Dorgeret L., Chevallier F., Besse D., Dufort M., Caussafe F., Ahmad S.Z., Stetsko DK., Skala S., Davis PM., Balimane P., Patel K., Yang Z., Marathe P., Postelneck J., Townsend RM., Goldfarb V., Sheriff S., Einspahr H., Kish K., Malley MF., Di Marco JD., Gougoutas JZ., Kadiyala P., Cheney DL., Tejwani RW., Murphy DK., McIntyre KW., Yang X., Chao S., Leith L., Xiao Z., Mathur A., Chen BC., Wu DR., Traeger SC., McKinnon M., Barrish JC., Robl JA., Iwanowicz EJ., Suchard SJ., Dhar TG. |
| J. Med. Chem., 49 (24): 6946-6949 |
|
|
| Fuzzy Tricentric Pharmacophore Fingerprints. Topological Fuzzy Pharmacophore Triplets and Adapted Molecular Similarity Scoring Schemes |
| Bonachéra, F., Parent, B., Barbosa, F., Froloff, N. & Horvath, D. |
| Journal of Chemical Information and Modeling, 46, 2457-2477 |
|
|
| High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model usign high content screening |
| P.J. O'Brien, W. Irwin, D. Diaz, E. Howard-Cofield, C.M. Kresja, M.R. Slaughter, B. Gao, N. Kaludercic, A. Angline, P. Bernardi, P. Brain, C. Hougham |
| Arch. Toxicol (2006), DO1 10.1007/s00204-006-0091-3 |
|
|
| Identifying human toxicity potential: Defining the Sequence of Events in Statin Toxicity using a High Content Cytotoxicity Assay |
| Diaz, D. and O’Brien, P.J. |
| European Pharmaceutical review, 11, 4, 38-45 |
|
|
| QSAR modeling of in vitro inhibition of cytochrome P450 3A4 |
| Mao, B., Gozalbes, R., Barbosa, F., Migeon, J., Merrick, S., Kamm, K., Wong, E., Costales, C., Shi, W., Wu, C. & Froloff, N. |
| Journal of Chemical Information and Modeling, 46, 2125-2134 |
|
|
| The BioPrint Approach for the Evaluation of ADME Properties: Application to the Prediction of Cytochrome P450 2D6 Inhibition |
| Gozalbes R., Barbosa F., Froloff N., Horvath D. |
| Book Chapter in the Monograph: Pharmacokinetic Profiling in Drug Research, Chapt 23, pp395-415 |
|
|
| The BioPrint® approach for the evaluation of ADMET properties: application to the prediction of cytochrome P450 2D6 inhibition. |
| Gozalbes, R., Barbosa, F., Froloff, N. & Horvath, D |
| Testa, B., Krämer, S.D., Wunderli-Allenspach, H. & Folkers, G. (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, VHCA, Zürich, WILEY-VCH, Weinheim, pp. 395-415 |
|
|
|
 |
|
